FibroCell Science: Jefferies Global Healthcare Conference (Fibrocell Science) - Jun 3, 2015 - “Positive Phase I clinical trial results published in peer-reviewed journal”; “All patients completed the clinical trial, successive injections of autologous fibroblasts were well-tolerated, and no serious adverse events reported; n=5”; “Statistically significant and sustained improvement: Efficacy analysis for wave grade improvements was significant starting in month 3 of the 12 month clinical trial (p=0.04), Voice Handicap Index and Voice Quality assessments showed an improvement in voice quality overall for the duration of the clinical trial”
P1 data • Fibrosis
|